- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07499232
Une étude du guselkumab contre le risankizumab chez des participants atteints de la maladie de Crohn modérément à sévèrement active (CHARGE)
Une étude de phase 3b, multicentrique, randomisée, ouverte, contrôlée active, comparant l'efficacité et l'innocuité du guselkumab par rapport au risankizumab dans le traitement des participants atteints de la maladie de Crohn modérément à sévèrement active
The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- Phase 3
Contacts et emplacements
Coordonnées de l'étude
- Nom: Study Contact
- Numéro de téléphone: 844-434-4210
- E-mail: Participate-In-This-Study1@its.jnj.com
Lieux d'étude
-
-
-
Berlin, Allemagne, 10825
- Recrutement
- GASTRO-Studien
-
Berlin, Allemagne, 12203
- Recrutement
- Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin (CBF)
-
Erlangen, Allemagne, 91054
- Recrutement
- Universitatsklinikum Erlangen
-
Grevenbroich, Allemagne, 41515
- Recrutement
- Praxiszentrum Fur Gastroenterologie und Endoskopie Grevenbroich
-
Jena, Allemagne, 07747
- Recrutement
- Universitatsklinikum Jena
-
Kiel, Allemagne, 24105
- Recrutement
- Universitatsklinikum Schleswig Holstein Kiel
-
Ludwigshafen am Rhein, Allemagne, 67067
- Recrutement
- St. Marien und St. Annastiftskrankenhaus
-
Mannheim, Allemagne, 68167
- Recrutement
- Universitaetsklinikum Mannheim
-
München, Allemagne, 81675
- Recrutement
- Klinikum rechts der Isar der TU Munchen
-
-
-
-
-
Brussels, Belgique, 1200
- Recrutement
- Cliniques Universitaires Saint Luc
-
Brussels, Belgique, 1070
- Recrutement
- ULB Erasme Ziekenhuis
-
Genk, Belgique, 3600
- Recrutement
- Ziekenhuis Oost-Limburg
-
Ghent, Belgique, 9000
- Recrutement
- Ghent University Hospital
-
Leuven, Belgique, 3000
- Recrutement
- Universitair Ziekenhuis Leuven
-
Liège, Belgique, 4000
- Recrutement
- CHU de Liege
-
Roeselare, Belgique, 8800
- Recrutement
- Algemeen Ziekenhuis Delta
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada, T5R 1W2
- Recrutement
- Gastroenterology and Internal Medicine Research Institute (GIRI)
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 2K5
- Recrutement
- GIRI Gastrointestinal Research Institute
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N1Y2
- Recrutement
- Charlton Digestive Disease Centre
-
London, Ontario, Canada, N6K 1M6
- Recrutement
- London Digestive Disease Institute
-
Oshawa, Ontario, Canada, L1J 0C7
- Recrutement
- Taunton Surgical Centre
-
Toronto, Ontario, Canada, M6A 3B4
- Recrutement
- Toronto Immune and Digestive Health Institute Inc
-
-
Quebec
-
Montreal, Quebec, Canada, H3H1E3
- Recrutement
- Clinique IMD
-
Montreal, Quebec, Canada, H2X 0C1
- Recrutement
- Centre Hospitalier de l'Universite de Montreal
-
-
-
-
-
Changzhou, Chine, 213018
- Recrutement
- Changzhou No 2 Peoples Hospital
-
Chongqing, Chine, 400014
- Recrutement
- Chongqing General Hospital
-
Fuzhou, Chine, 350005
- Recrutement
- The First Affiliated Hospital of Fujian Medical University
-
Guangzhou, Chine, 510655
- Recrutement
- The Sixth Affiliated Hospital Sun Yat sen University
-
Guangzhou, Chine, 510261
- Recrutement
- The Second Affiliated Hospital of Guangzhou Medical University
-
Nanjing, Chine, 210009
- Recrutement
- Zhongda Hospital Southeast University
-
Wuhan, Chine, 430060
- Recrutement
- Renmin Hospital of Wuhan University
-
-
-
-
-
Aarhus C, Danemark, 8200
- Recrutement
- Aarhus University Hospital
-
Esbjerg, Danemark, 6700
- Recrutement
- Sydvestjysk Sygehus
-
Gistrup, Danemark, 9260
- Recrutement
- NAU New Aalborg University Hospital
-
Herlev, Danemark, 2730
- Recrutement
- Herlev Hospital
-
Hilleroed, Danemark, 3400
- Recrutement
- Nordsjaellands Hospital, Hillerod
-
Hvidovre, Danemark, 2650
- Recrutement
- Hvidovre Hospital
-
København NV, Danemark, 2400
- Recrutement
- Bispebjerg Hospital
-
Odense C, Danemark, 5000
- Recrutement
- Odense UH og Svendberg sygehus
-
-
-
-
-
Alicante, Espagne, 03010
- Recrutement
- Hosp. Gral. Univ. Dr. Balmis
-
Barcelona, Espagne, 08036
- Recrutement
- Hosp. Clinic de Barcelona
-
Ferrol, Espagne, 15405
- Recrutement
- Hosp. Arquitecto Marcide
-
Gijón, Espagne, 33394
- Recrutement
- Hosp. de Cabuenes
-
Girona, Espagne, 17007
- Recrutement
- Hosp. Univ. Dr. Josep Trueta
-
Madrid, Espagne, 28850
- Recrutement
- Hosp. Univ. de Torrejon
-
Navarra, Espagne, 31008
- Recrutement
- Hosp. de Navarra
-
Santiago de Compostela, Espagne, 15706
- Recrutement
- Hosp. Clinico Univ. de Santiago
-
Seville, Espagne, 41009
- Recrutement
- Hosp. Virgen Macarena
-
-
-
-
-
Amiens, France, 80000
- Recrutement
- CHU Amiens Picardie
-
Clermont-Ferrand, France, 63000
- Recrutement
- Clermont Ferrand University Hospital
-
Marseille, France, 13015
- Recrutement
- Aphm - Hopital Nord
-
Nantes, France, 44000
- Recrutement
- CHU Nantes - Hotel Dieu
-
Neuilly-sur-Seine, France, 92200
- Recrutement
- Clinique Ambroise Pare
-
Nîmes, France, 30900
- Recrutement
- CHU Nimes
-
Paris, France, 75018
- Recrutement
- APHP - Hopital Bichat - Claude Bernard
-
Paris, France, 75012
- Recrutement
- Aphp Hopital Saint Antoine
-
Pierre-Bénite, France, 69495
- Recrutement
- Hospices Civils de Lyon CHU Lyon Sud
-
Reims, France, 51100
- Recrutement
- CHU de Reims
-
Vandœuvre-lès-Nancy, France, 54511
- Recrutement
- Centre Hospitalier Universitaire de Nancy - Hôpital Central
-
Échirolles, France, 38130
- Recrutement
- Institut Prive MICI Clinique des Cedres
-
-
-
-
-
Budapest, Hongrie, 1088
- Recrutement
- Semmelweis Egyetem
-
Budapest, Hongrie, 1036
- Recrutement
- Obudai Egeszsegugyi Centrum Kft
-
Budapest, Hongrie, H-1136
- Recrutement
- Pannónia Magánorvosi Centrum Kft
-
Budapest, Hongrie, 1082
- Recrutement
- Semmelweis Egyetem 1
-
Budapest, Hongrie, 1083
- Recrutement
- Semmelweis Egyetem 2
-
Budapest, Hongrie, 1139
- Recrutement
- Endomedix
-
Gyöngyös, Hongrie, 3200
- Recrutement
- Clinexpert Gyongyos Kft
-
Szeged, Hongrie, 6725
- Recrutement
- Szegedi Tudomanyegyetem
-
-
-
-
-
Bologna, Italie, 40138
- Recrutement
- A O U Sant Orsola Malpighi
-
Bolzano, Italie, 39100
- Recrutement
- Azienda Sanitaria dell'Alto Adige - Ospedale di Bolzano
-
Genova, Italie, 16132
- Recrutement
- Azienda Ospedaliero Universitaria San Martino
-
Milan, Italie, 20132
- Recrutement
- IRCCS Ospedale San Raffaele
-
Roma, Italie, 00168
- Recrutement
- Fondazione Policlinico Universitario A Gemelli IRCCS
-
Rozzano, Italie, 20089
- Recrutement
- Istituto Clinico Humanitas
-
Torino, Italie, 10128
- Recrutement
- Ospedale Mauriziano Torino
-
-
-
-
-
Graz, L'Autriche, 8036
- Recrutement
- LKH-Univ. Klinikum Graz
-
Innsbruck, L'Autriche, 6020
- Recrutement
- Medizinische Universitatsklinik Innsbruck
-
Linz, L'Autriche, 4021
- Recrutement
- Kepler Universitatsklinikum GmbH
-
Salzburg, L'Autriche, 5020
- Recrutement
- LKH - Universitätsklinikum der PMU Salzburg
-
Vienna, L'Autriche, 1090
- Recrutement
- Medical University Vienna
-
Vienna, L'Autriche, 1020
- Recrutement
- Krankenhaus der Barmherzigen Brüder
-
Wels, L'Autriche, 4600
- Recrutement
- Klinikum Wels Grieskirchen
-
Wiener Neustadt, L'Autriche, 2700
- Recrutement
- Universitatsklinikum Wiener Neustadt
-
-
-
-
-
Maastricht, Pays-Bas, 6229 HX
- Recrutement
- Maastricht UMC
-
Nijmegen, Pays-Bas, 6525 GA
- Recrutement
- Radboud Umcn
-
Tilburg, Pays-Bas, 5022 GC
- Recrutement
- St. Elisabeth Ziekenhuis
-
-
-
-
-
Bydgoszcz, Pologne, 85 229
- Recrutement
- Centrum Medyczne Medis ManerMed Sp Z O O
-
Krakow, Pologne, 30363
- Recrutement
- Centrum Medyczne Plejady
-
Krakow, Pologne, 31-513
- Recrutement
- Centrum Medyczne Promed
-
Rzeszów, Pologne, 35-326
- Recrutement
- Centrum Medyczne 'Medyk' Sp. z o.o. K.
-
Szczecin, Pologne, 71-434
- Recrutement
- Twoja Przychodnia - Szczecinskie Centrum Medyczne
-
Torun, Pologne, 87 100
- Recrutement
- GASTROMED Kopon Zmudzinski i wspolnicy SP j Specjalistyczne Centrum Gastrologii i Endoskopii
-
Warsaw, Pologne, 02-781
- Recrutement
- Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
-
Warsaw, Pologne, 04 501
- Recrutement
- Medical Network Sp z o o
-
-
-
-
-
Greater London, Royaume-Uni, E1 2AJ
- Recrutement
- Barts Health NHS Trust
-
Greater London, Royaume-Uni, NW10 7NS
- Recrutement
- London North West University Healthcare NHS Trust
-
Iselworth, Royaume-Uni, TW7 6AF
- Recrutement
- West Middlesex University Hospital
-
London, Royaume-Uni, NW3 2QG
- Recrutement
- Royal Free Hospital
-
London, Royaume-Uni, W120HS
- Recrutement
- Imperial College London
-
London, Royaume-Uni, NW1 2PG
- Recrutement
- University College London Hospitals Nhs Foundation Trust
-
London, Royaume-Uni, SW10 9NH
- Recrutement
- Chelsea And Westminster Hospital
-
Norwich, Royaume-Uni, NR4 7UQ
- Recrutement
- Norfolk and Norwich University Hospital
-
Wolverhampton, Royaume-Uni, WV10 0QP
- Recrutement
- New Cross Hospital
-
-
-
-
-
Banská Bystrica, Slovaquie, 975 17
- Recrutement
- FNsP F. D. Roosevelta Banska Bystrica
-
Bratislava, Slovaquie, 811 09
- Recrutement
- Cliniq s.r.o.
-
Košice, Slovaquie, 040 13
- Recrutement
- ENDOMED s.r.o
-
Nové Zámky, Slovaquie, 940 34
- Recrutement
- Fakultna nemocnica s poliklinikou Nove Zamky
-
Prešov, Slovaquie, 080 01
- Recrutement
- GASTRO I. s.r.o.
-
Prešov, Slovaquie, 080 01
- Recrutement
- Gastro LM s.r.o.
-
Rimavská Sobota, Slovaquie, 979 12
- Recrutement
- Vseobecna nemocnica Rimavska Sobota
-
-
-
-
-
Linköping, Suède, 58185
- Recrutement
- Linkoping University Hospital
-
Mölndal, Suède, 431 30
- Recrutement
- Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
-
Stockholm, Suède, 171 76
- Recrutement
- Karolinska Universitetssjukhuset
-
Stockholm, Suède, 116 30
- Recrutement
- Ersta sjukhus
-
Stockholm, Suède, 118 83
- Recrutement
- Sodersjukhuset
-
Uppsala, Suède, 751 85
- Recrutement
- Akademiska Sjukhuset
-
-
-
-
-
Brno, Tchéquie, 62500
- Recrutement
- Fakultni nemocnice Brno
-
Brno, Tchéquie, 636 00
- Recrutement
- Vojenska nemocnice Brno
-
Hradec Kralova, Tchéquie, 500 02
- Recrutement
- Gastroenterologie, s.r.o., Hradec Kralove
-
Hradec Králové, Tchéquie, 500 12
- Recrutement
- Hepato-gastroenterologie HK, s.r.o.
-
Ostrava-Poruba, Tchéquie, 708 00
- Recrutement
- Fakultni Nemocnice Ostrava
-
Prague, Tchéquie, 100 00
- Recrutement
- Fakultni nemocnice Kralovske Vinohrady
-
Prague, Tchéquie, 14000
- Recrutement
- Fakultni Thomayerova nemocnice
-
-
-
-
Alabama
-
Dothan, Alabama, États-Unis, 36305
- Recrutement
- Digestive Health Specialists of the Southeast
-
Mobile, Alabama, États-Unis, 36608
- Recrutement
- East View Medical Research
-
-
California
-
Anaheim, California, États-Unis, 92805
- Recrutement
- Clinnova Research
-
Lancaster, California, États-Unis, 93534
- Recrutement
- Gastro Care Institute
-
Los Alamitos, California, États-Unis, 90720
- Recrutement
- United Gastroenterologists
-
Los Angeles, California, États-Unis, 90048
- Recrutement
- TLC Clinical Research Inc
-
Los Angeles, California, États-Unis, 90067
- Recrutement
- GastroIntestinal Bioscience
-
San Diego, California, États-Unis, 92123
- Recrutement
- Medical Associates Research Group, Inc.
-
-
Colorado
-
Colorado Springs, Colorado, États-Unis, 80907
- Recrutement
- Peak Gastroenterology Associates
-
-
Connecticut
-
Hamden, Connecticut, États-Unis, 06518
- Recrutement
- Medical Research Center of Connecticut
-
-
Florida
-
Jacksonville, Florida, États-Unis, 32258
- Recrutement
- Green Leaf Clinical Trials
-
Miami, Florida, États-Unis, 33157-6575
- Recrutement
- Sanchez Clinical Research, Inc
-
Miami, Florida, États-Unis, 33186
- Recrutement
- Biodax Medical Research Trials
-
Naples, Florida, États-Unis, 34102
- Recrutement
- GI Pros Research
-
Orlando, Florida, États-Unis, 32806
- Recrutement
- Orlando Health Digestive Health Institute
-
Tampa, Florida, États-Unis, 33609
- Recrutement
- GCP Clinical Research
-
-
Georgia
-
Atlanta, Georgia, États-Unis, 30310
- Recrutement
- Morehouse School of Medicine
-
Atlanta, Georgia, États-Unis, 30342
- Suspendu
- Atlanta Gastroenterology Associates
-
Macon, Georgia, États-Unis, 31201
- Recrutement
- Gastroenterology Associates of Central GA
-
-
Illinois
-
Northbrook, Illinois, États-Unis, 60062
- Recrutement
- Comprehensive Gastrointestinal Health Libertyville
-
-
Iowa
-
Clive, Iowa, États-Unis, 50325
- Recrutement
- Heartland Medical Research Inc
-
-
Kansas
-
Topeka, Kansas, États-Unis, 66606
- Recrutement
- Cotton-O'Neil Clinical Research Center
-
-
Louisiana
-
Lafayette, Louisiana, États-Unis, 70503
- Recrutement
- Gastroenterology Clinic of Acadiana
-
Shreveport, Louisiana, États-Unis, 71103
- Recrutement
- Louisiana State University Health Sciences Center Shreveport
-
-
Maryland
-
Glen Burnie, Maryland, États-Unis, 21061
- Recrutement
- Woodholme Gastroenterology Associates
-
-
Massachusetts
-
New Bedford, Massachusetts, États-Unis, 02740
- Recrutement
- Lucida Clinical Trials
-
-
Michigan
-
Farmington Hills, Michigan, États-Unis, 48334
- Recrutement
- Michigan Center of Medical Research
-
-
New York
-
Carmel, New York, États-Unis, 10512
- Recrutement
- Westchester Putnam Gastroenterology
-
New York, New York, États-Unis, 10028
- Recrutement
- New York Gastroenterology Associates
-
New York, New York, États-Unis, 10075
- Suspendu
- Lenox Hill Hospital
-
-
North Carolina
-
Chapel Hill, North Carolina, États-Unis, 27599 7080
- Recrutement
- University of North Carolina at Chapel Hill
-
Charlotte, North Carolina, États-Unis, 28207
- Recrutement
- Charlotte Gastroenterology and Hepatology, PLLC
-
-
Ohio
-
Mentor, Ohio, États-Unis, 44060
- Recrutement
- Great Lakes Gastroenterology Research, LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, États-Unis, 73114
- Recrutement
- Digestive Disease Specialists Inc
-
-
Pennsylvania
-
Uniontown, Pennsylvania, États-Unis, 15401
- Recrutement
- Frontier Clinical Research
-
-
South Carolina
-
Summerville, South Carolina, États-Unis, 29486
- Recrutement
- Palmetto Primary and Specialty Care Physicians, Charleston
-
-
Texas
-
Carrollton, Texas, États-Unis, 75010
- Recrutement
- DFW Clinical Trials
-
Lubbock, Texas, États-Unis, 79424
- Recrutement
- Lubbock Gastroenterology
-
San Antonio, Texas, États-Unis, 78229
- Recrutement
- Gastroenterology Research of America, LLC
-
San Antonio, Texas, États-Unis, 78229
- Recrutement
- Southern Star Research Institute, LLC
-
Tyler, Texas, États-Unis, 75708
- Recrutement
- The University of Texas Health Science Center at Tyler
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion criteria:
-
Has CD or fistulizing Crohn's Disease (CD) of at least 12 weeks' duration, with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, and/or endoscopy
-
Have moderately to severely active CD, defined as baseline Crohn's Disease Activity Index (CDAI) score greater than or equal to (>=) 220 but less than or equal to (<=) 450
-
Baseline endoscopic evidence of active ileal and/or colonic CD as assessed by central endoscopy reading at the screening endoscopy defined as a screening Simple Endoscopic Score for Crohn's Disease (SES CD) >= 4 (for participants with isolated ileal disease) or >= 6 (for participants with colonic or ileocolonic disease), based on the presence of ulceration in any 1 of the 5 ileocolonic segments, resulting in the following specified ulceration component scores:
- a minimum score of 1 for the component of "size of ulcers" AND
- a minimum score of 1 for the component of "ulcerated surface"
-
In the opinion of the investigator, participant's disease is appropriate to treat with the maintenance dosing regimens utilized in the study
-
Adhere to the requirements for concomitant medications for the treatment of CD as mentioned in the protocol
Exclusion criteria
- Has complications of CD such as symptomatic strictures or stenoses, short gut syndrome, active draining stoma or significant fistulizing disease or any other manifestation anticipated to require surgery within the next year, could preclude the use of the CDAI to assess response to therapy, or would possibly confound the ability to assess the effect of treatment with guselkumab or risankizumab
- Currently has or is suspected to have an abscess
- Has an active fistula during screening or at Week 0 with an anticipated need for surgery
- Has had any kind of bowel resection within 24 weeks, or any other intra-abdominal or other major surgery within 12 weeks, before first dose of study intervention
- Currently has a malignancy or has a history of malignancy within 5 years before screening
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Guselkumab
Participants will receive guselkumab induction dose subcutaneously (SC) at Weeks 0, 4, and 8 followed by guselkumab maintenance dose SC once every 4 weeks (q4w) from Week 12 through Week 52. |
Guselkumab will be administered.
Autres noms:
|
|
Expérimental: Risankizumab
Participants will receive risankizumab induction dose intravenously (IV) at Weeks 0, 4, and 8 followed by risankizumab maintenance dose SC once every 8 weeks (q8w) from Week 12 through Week 52. |
Risankizumab will be administered. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of Participants with Deep Remission at Week 52
Délai: At Week 52
|
Deep remission is a composite endpoint defined as achieving both clinical remission and endoscopic remission at the participant level. Clinical remission is defined as Crohn's Disease Activity Index (CDAI) score less than (<) 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic remission is defined as Simple Endoscopic Score for Crohn's Disease (SES-CD) less than or equal to (<=) 4 with at least a 2-point reduction from baseline and no sub score greater than (>) 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Composite Endpoint of Number of Participants with Clinical Remission and Endoscopic Response at Week 52
Délai: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic response is defined as >50 percent (%) improvement from baseline in the SES CD or SES-CD score <= 2 or a decrease of at least 2 points in participants with a baseline score of 4 and isolated ileal disease. This is a composite endpoint defined to measure achievement of both clinical remission and endoscopic response. |
At Week 52
|
|
Number of Participants with Endoscopic Remission at Week 52
Délai: At Week 52
|
Endoscopic remission is defined as SES-CD <= 4 with at least a 2-point reduction from baseline and no sub score > 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
|
Number of Participants with Clinical Remission at Week 52
Délai: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. |
At Week 52
|
|
Number of Participants with Steroid-Free Clinical Remission at Week 52
Délai: At Week 52
|
Steroid-free clinical remission is defined as clinical remission at Week 52 and not receiving corticosteroids for at least 90 days prior to Week 52. Clinical remission is defined as CDAI score < 150-point. |
At Week 52
|
|
Number of Participants with Abnormalities in Laboratory Parameters
Délai: Up to Week 148
|
Number of participants with abnormalities in laboratory parameters (hematology and chemistry) will be reported. |
Up to Week 148
|
|
Number of Participants With Change From Baseline in Laboratory Abnormalities
Délai: Up to week 148
|
Number of participants with change from baseline in laboratory abnormalities (hematology and chemistry) will be reported. |
Up to week 148
|
|
Number of Participants with Adverse Events (AEs), Serious AEs and AEs Leading to Discontinuation of Study Intervention
Délai: Up to Week 165
|
An AE is any untoward medical occurrence in a participant administered a pharmaceutical (investigational or non investigational) product. An AE does not necessarily have a causal relationship with the treatment. An SAE is any untoward medical occurrence that at any dose results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, is a suspected transmission of any infectious agent via a medicinal product and is medically important. |
Up to Week 165
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CNTO1959CRD3009
- CNTO1959CRD3009 (Autre identifiant: Janssen Research & Development, LLC)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
The data sharing policy of Johnson & Johnson Innovative Medicine is available at www.innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .